These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Clinical features of infantile patient with juvenile rheumatoid arthritis]. Maeno N; Imanaka H; Takei S; Hizukuri K; Shigemori M; Miyata K; Hokonohara M Ryumachi; 1994 Oct; 34(5):901-7. PubMed ID: 7801204 [TBL] [Abstract][Full Text] [Related]
11. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. Emlen W; Niebur J; Flanders G; Rutledge J J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125 [TBL] [Abstract][Full Text] [Related]
12. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. De Benedetti F; Massa M; Pignatti P; Kelley M; Faltynek CR; Martini A J Rheumatol; 1995 Aug; 22(8):1581-5. PubMed ID: 7473488 [TBL] [Abstract][Full Text] [Related]
13. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis. Huemer C; Malleson PN; Cabral DA; Huemer M; Falger J; Zidek T; Petty RE J Rheumatol; 2002 Jul; 29(7):1531-5. PubMed ID: 12136915 [TBL] [Abstract][Full Text] [Related]
14. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. Oen K; Malleson PN; Cabral DA; Rosenberg AM; Petty RE; Reed M; Schroeder ML; Cheang M J Rheumatol; 2003 Mar; 30(3):585-93. PubMed ID: 12610821 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. Walker SM; Shaham B; McCrudy DK; Wietting H; Arora YK; Hanson V; Bernstein B J Rheumatol; 1990 Jul; 17(7):936-40. PubMed ID: 2213760 [TBL] [Abstract][Full Text] [Related]
16. RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Yao TC; Kuo ML; See LC; Ou LS; Lee WI; Chan CK; Huang JL Arthritis Rheum; 2006 Aug; 54(8):2585-93. PubMed ID: 16868981 [TBL] [Abstract][Full Text] [Related]
17. Measuring disability in early juvenile rheumatoid arthritis: evaluation of a Norwegian version of the childhood Health Assessment Questionnaire. Flatø B; Sørskaar D; Vinje O; Lien G; Aasland A; Moum T; Førre O J Rheumatol; 1998 Sep; 25(9):1851-8. PubMed ID: 9733471 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Pauls JD; Silverman E; Laxer RM; Fritzler MJ Arthritis Rheum; 1989 Jul; 32(7):877-83. PubMed ID: 2787640 [TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis. Silverman ED; Laxer RM; Nelson DL; Rubin LA J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944 [TBL] [Abstract][Full Text] [Related]
20. Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis. Majeed M; McQueen F; Yeoman S; McLean L Ann Rheum Dis; 2004 Sep; 63(9):1166-8. PubMed ID: 15308530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]